Risks in mass distribution of potassium iodide.
作者信息
Yalow R S
出版信息
Bull N Y Acad Med. 1983 Dec;59(10):1020-7.
Abstract
摘要
相似文献
1
Risks in mass distribution of potassium iodide.碘化钾大规模分发中的风险。
Bull N Y Acad Med. 1983 Dec;59(10):1020-7.
2
Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution.碘化钾作为甲状腺阻滞剂使用的生理基础及其分发中的后勤问题。
Bull N Y Acad Med. 1983 Dec;59(10):1003-8.
3
Indications for using potassium iodide to protect the thyroid from low level internal irradiation.使用碘化钾保护甲状腺免受低水平内照射的指征。
Bull N Y Acad Med. 1983 Dec;59(10):1028-38.
4
Recommendations on the use of potassium iodide as a thyroid-blocking agent in radiation accidents: an FDA update.关于在辐射事故中使用碘化钾作为甲状腺阻断剂的建议：美国食品药品监督管理局的最新情况
Bull N Y Acad Med. 1983 Dec;59(10):1009-19.
5
Nuclear power plant emergencies and thyroid cancer risk. What New Jersey physicians need to know.核电站事故与甲状腺癌风险。新泽西州医生需要了解的内容。
N J Med. 2004 Apr;101(4):22-7; quiz 28-30.
6
An anti-nuclear shield for your thyroid.为你的甲状腺提供抗核防护。
Johns Hopkins Med Lett Health After 50. 2002 Oct;14(8):6-7.
7
In accidents, give KI promptly.
Health Phys. 1985 Dec;49(6):1311-3.
8
9
Some aspects of emergency planning for nuclear reactor accidents by New York City.纽约市针对核反应堆事故的应急规划的某些方面。
Bull N Y Acad Med. 1983 Dec;59(10):981-7.
10
France distributes iodine near reactors.法国在反应堆附近分发碘。
Science. 1997 Mar 28;275(5308):1871-2. doi: 10.1126/science.275.5308.1871b.
引用本文的文献
1
Nuclear denotation: A topic for global public health concern.核辐射：一个全球公共卫生关注的话题。
Indian J Nucl Med. 2011 Jan;26(1):56-7. doi: 10.4103/0972-3919.84619.
2
Nuclear detonation, thyroid cancer and potassium iodide prophylaxis.核爆炸、甲状腺癌与碘化钾预防
Indian J Endocrinol Metab. 2011 Apr;15(2):96-8. doi: 10.4103/2230-8210.81937.
本文引用的文献
1
Observations on iodide sensitivity.关于碘化物敏感性的观察结果。
Ann Allergy. 1957 Mar-Apr;15(2):158-64.
2
Thyroid cancer in Connecticut, 1935-1975: an analysis by cell type.1935 - 1975年康涅狄格州的甲状腺癌：按细胞类型进行的分析
Am J Epidemiol. 1980 Dec;112(6):764-74. doi: 10.1093/oxfordjournals.aje.a113049.
3
Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. I. Retrospective cohort study.诊断剂量的碘-131照射后人类甲状腺恶性肿瘤的发病率。I. 回顾性队列研究。
J Natl Cancer Inst. 1980 May;64(5):1055-9.
4
Thyroid disease in children. A survey of subjects potentially exposed to fallout radiation.
Am J Med. 1974 Apr;56(4):457-63. doi: 10.1016/0002-9343(74)90476-8.
5
Hyperthyroidism induced by potassium iodide given in the course of 125I-fibrinogen test.在125I-纤维蛋白原试验过程中给予碘化钾所致的甲状腺功能亢进。
Age Ageing. 1974 Nov;3(4):221-5. doi: 10.1093/ageing/3.4.221.
6
Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis.四名低补体血症性血管炎患者的碘化钾敏感性
Ann Intern Med. 1979 Dec;91(6):853-7. doi: 10.7326/0003-4819-91-6-853.
7
Value of postirradiation screening for thyroid nodules. A controlled study of recalled patients.甲状腺结节放疗后筛查的价值。对召回患者的对照研究。
JAMA. 1979 Dec 14;242(24):2675-8.
8
Dermatologic adverse drug reactions in hospitalized patients.住院患者的皮肤药物不良反应
Am J Hosp Pharm. 1979 May;36(5):609-12.
Zotero 插件